News & Updates

Poor environmental quality is associated with greater odds of an advanced stage prostate cancer at diagnosis, with a study finding the strongest associations for lower water, land, sociodemographic quality.

Enrolment in clinical trials does not seem to increase survival among patients with multiple myeloma, a recent study has found.

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.